Question 1

What is PRAX's ST Score?

Accepted Answer

Praxis Precision Medicines, Inc. (PRAX) has an ST Score of 62.9 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Question 2

Is PRAX a buy, sell, or hold?

Accepted Answer

Wall Street's consensus rating on PRAX is Buy based on 18 analyst ratings. Our own ST Score grades it B (62.9/100). This is data, not investment advice — always do your own research.

Question 3

What is PRAX's valuation grade?

Accepted Answer

Praxis Precision Medicines, Inc. (PRAX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Question 4

What is PRAX's growth grade?

Accepted Answer

Praxis Precision Medicines, Inc. (PRAX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Question 5

What is PRAX's profitability grade?

Accepted Answer

Praxis Precision Medicines, Inc. (PRAX) earns a profitability grade of B+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Question 6

What is PRAX's financial strength grade?

Accepted Answer

Praxis Precision Medicines, Inc. (PRAX) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

Question 7

What is the analyst price target for PRAX?

Accepted Answer

The average analyst price target for Praxis Precision Medicines, Inc. (PRAX) is $603.83 from 18 analysts, which is +1.0% versus the recent price of $300.65.

Question 8

What is PRAX's Piotroski score?

Accepted Answer

Praxis Precision Medicines, Inc. (PRAX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.

Praxis Precision Medicines, Inc. (PRAX) Analyst Ratings & Price Targets

What are stock analyst ratings and what do they mean?

What is the average analyst price target for PRAX?

Are stock analyst ratings useful?

How often are PRAX's analyst ratings updated?

What is the current Praxis Precision Medicines, Inc. (PRAX) stock price?

What sector and industry does PRAX operate in?

What is PRAX's market cap?

How many employees does PRAX have?